A randomized controlled trial to evaluate the effects of a comprehensive sexual rehabilitation curriculum tailored for gay and bisexual prostate cancer survivors: 12-month Interim Results from the Restore-2 study

-
In Person 11/1
Presenters

B.R.Simon Rosser, PhD, MPH, LP
Professor, Div of Epidemiology & Community Health

Host
Poynter